Clinical Trial

Normalized Glucose Levels in Type 2 Diabetes With Carbohydrate or Caloric Restriction

Study acronym: CarborCal
Recruiting
View on ClinicalTrials.gov →
Summary
This is a randomized controlled trial to determine whether a low-carbohydrate (LC) diet can lead to normalized blood glucose levels in patients with short duration of type 2 diabetes (T2D). Previous studies have shown that caloric restricted diet leading to weight loss can normalize blood glucose levels in approximately 50% of patients with a short duration of diabetes type 2. However, caloric restriction is difficult to maintain. Less restrictive approaches are needed. The hypothesis in this study is that Low carbohydrate diet can results in normalized blood glucose levels in T2D and can be an alternative to caloric restriction diet, both in the shorter term (3 months) and longer term (15 months). The outcome of this study leading to reduction of HbA1c is important for prevention of diabetes complications.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-03-24; most recent amendment 2023-12-27.
Trial Details
NCT Number NCT05801614
Lead Sponsor Region Stockholm
Conditions Diabetes Mellitus Type 2 in Obese
Enrollment 286 participants
Start Date 2022-02-28
Primary Completion 2027-02-28 (estimated)
Study Completion 2027-02-28 (estimated)
Updated on ClinicalTrials.gov 2024-01-02